Alexander C Razavi
Overview
Explore the profile of Alexander C Razavi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
547
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ahmad M, Chevli P, Mirzai S, Rikhi R, Bhatia H, Pagidipati N, et al.
Prog Cardiovasc Dis
. 2025 Mar;
PMID: 40081639
Aims: To assess if adiposity measures such as waist-to-hip ratio (WHR) modify the relationship of lipoprotein (a) [Lp(a)] with atherosclerotic cardiovascular disease (ASCVD). Methods: 4652 participants from the Multi-Ethnic Study...
2.
Chevli P, Razavi A, Evans J, Kazibwe R, Connelly M, Khan S, et al.
J Cardiovasc Comput Tomogr
. 2025 Feb;
PMID: 39924402
No abstract available.
3.
Razavi A, Whelton S, Al-Mallah M
Atherosclerosis
. 2025 Feb;
402:119105.
PMID: 39909813
No abstract available.
4.
Razavi A, Dzaye O, Cainzos-Achirica M, Dardari Z, van Assen M, Quyyumi A, et al.
Am J Prev Cardiol
. 2025 Feb;
21:100916.
PMID: 39896051
Background: Calcification of the ascending and/or descending thoracic aorta is easily measured via non-contrast cardiac computed tomography (CT), commonly performed for quantification of coronary artery calcium (CAC). We assessed whether...
5.
Berning P, Adhikari R, Schroer A, Jelwan Y, Razavi A, Blaha M, et al.
JAMA Netw Open
. 2025 Jan;
8(1):e2457232.
PMID: 39878977
Importance: Obesity, a chronic disease with escalating global prevalence, poses considerable health risks. Glucagon-like peptide 1 receptor agonists (GLP-1RAs), including liraglutide, semaglutide, and tirzepatide, have demonstrated efficacy for weight loss...
6.
Razavi A, Vaccarino V, Blumenthal R
JACC Adv
. 2025 Jan;
4(2):101537.
PMID: 39867499
No abstract available.
7.
Osei J, Razavi A, Otchere B, Bonful G, Akoto N, Akyea R, et al.
JACC Adv
. 2025 Jan;
3(12):101297.
PMID: 39817076
Background: Familial hypercholesterolemia (FH) is a common genetic disorder that is strongly associated with premature cardiovascular disease. Effective diagnosis and appropriate treatment of FH can reduce cardiovascular disease risk; however,...
8.
Razavi A, Cao Zhang A, Dardari Z, Nasir K, Khorsandi M, Mortensen M, et al.
JACC Cardiovasc Imaging
. 2025 Jan;
PMID: 39797878
Background: Implementation of semaglutide weight loss therapy has been challenging due to drug supply and cost, underscoring a need to identify those who derive the greatest absolute benefit. Objectives: Allocation...
9.
Yadalam A, Gold M, Patel K, Liu C, Razavi A, Jain V, et al.
JACC Adv
. 2024 Dec;
4(1):101442.
PMID: 39737138
Background: Higher soluble urokinase plasminogen activator receptor (suPAR) levels are associated with adverse outcomes in chronic heart failure (HF). Objectives: The authors assessed the association between proteomics-based suPAR levels and...
10.
Razavi A, Reyes M, Wilkins J, Szklo M, Tsai M, Whelton S, et al.
Eur J Prev Cardiol
. 2024 Nov;
PMID: 39607751
Aims: To assess the association of traditional risk factor burden and Life's Simple 7 (LS7) score with incident atherosclerotic cardiovascular disease (ASCVD) across Lp(a) levels. Methods: There were 6,676 participants...